Gedeon Richter Teases Denosumab Partnering Opportunity In Japan

Prolia/Xgeva Biosimilar US And EU Filings Are Expected Later In 2024

 
• By Urtė Fultinavičiūtė
  
Business card with the Japanese flag
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products